Enveric Biosciences (ENVB)
NASDAQ:ENVB

Enveric Biosciences (ENVB) Financial Statements

439 Followers

Enveric Biosciences Financial Overview

Enveric Biosciences's market cap is currently ―. The company's EPS TTM is $-6.417; its P/E ratio is -0.07; Enveric Biosciences is scheduled to report earnings on March 27, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ 2.50M$ -4.23M$ -2.82M$ -6.36M$ 5.03M
EBITDA$ 2.58M$ -4.15M$ -2.72M$ -6.24M$ 5.14M
Net Income Common Stockholders$ -2.46M$ -3.44M$ -2.82M$ -6.40M$ 5.15M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 6.36M$ 2.29M$ 4.27M$ 7.08M$ 12.56M
Total Assets$ 8.85M$ 4.30M$ 6.62M$ 9.80M$ 15.85M
Total Debt$ 0.00$ 0.00$ 0.00$ 9.61K$ 37.04K
Net Debt$ -6.36M$ -2.29M$ -4.27M$ -7.07M$ -12.52M
Total Liabilities$ 2.35M$ 2.34M$ 4.18M$ 4.93M$ 4.30M
Stockholders Equity$ 6.48M$ 1.96M$ 2.44M$ 4.87M$ 10.41M
Cash Flow-
Free Cash Flow$ -2.60M$ -1.75M$ -2.74M$ -4.45M$ -5.14M
Operating Cash Flow$ -2.60M$ -1.75M$ -2.74M$ -4.47M$ -5.14M
Investing Cash Flow-$ -38.00$ 20.00$ 16.85K$ -5.17K
Financing Cash Flow$ 6.66M$ -186.08K$ -105.00K$ -1.05M-
Currency in USD

Enveric Biosciences Earnings and Revenue History

Enveric Biosciences Debt to Assets

Enveric Biosciences Cash Flow

Enveric Biosciences Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis